Sort
261,768 grants matching “gene therapy”
Clinical Analysis of Disorders of Hearing and Balance
$1,445,094Carmen Crowell Brewer · National Institute On Deafness And Other Communication Disorders · ZIA · FY2021 · DC
Function Of Skeletal Matrix Genes
$1,444,402Marian F Young · National Institute Of Dental & Craniofacial Research · ZIA · FY2013 · DE
Precision Medicine of Cancer
$1,444,352Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
p53, Aging, and Cancer
$1,444,352Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Viral And Cellular Factors Governing Efficient Gene Delivery
$1,444,105Maribeth V. Eiden · National Institute Of Mental Health · Z01 · FY2008 · MH
Mechanisms of Esophageal Carcinogenesis
$1,443,822University Of Pennsylvania · P01 · FY2004 · CA
UCLA SPORE in Prostate Cancer
$1,443,180Robert E Reiter · University Of California Los Angeles · P50 · FY2021 · CA
Hypoxia--Molecular Studies and Clinical Exploitation
$1,443,138Stanford University · P01 · FY2002 · CA
Restoring Vision with High-Fidelity Nonsense Codon Correction
$1,443,079Bikash Ranjan Pattnaik · University Of Wisconsin-Madison · R24 · FY2022 · EY
Center of Research Translation in Muscular Dystrophy Therapeutic Development
$1,443,070Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · P50 · FY2019 · AR
Strategies to Optimize Pig-to Primate Kidney Xenograft Survival
$1,442,779Andrew B Adams · University Of Minnesota · U01 · FY2022 · AI
Strategies to Optimize Pig-to Primate Kidney Xenograft Survival
$1,442,779Andrew B Adams · University Of Minnesota · U01 · FY2023 · AI
Strategies to Optimize Pig-to Primate Kidney Xenograft Survival
$1,442,779Andrew B Adams · University Of Minnesota · U01 · FY2024 · AI
Therapeutic approaches for ABCA4-associated disorders
$1,442,474Rando L Allikmets · Columbia University Health Sciences · R24 · FY2012 · EY
Endocannabinoids And Energy Homeostasis
$1,442,319George Kunos · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Retinal Circuit Development & Genetics
$1,442,239Tudor Badea · National Eye Institute · ZIA · FY2011 · EY
Pathogenesis of Novel Forms of Osteogenesis Imperfecta
$1,441,874Brendan Hl Lee · Baylor College Of Medicine · P01 · FY2016 · HD
Tissue Bank
$1,441,797Rona S Weinberg · Icahn School Of Medicine At Mount Sinai · P01 · FY2009 · CA
Development of N-tert-(Butyl)hydroxylamine (NtBuHA) as a therapeutic agent for treating Infantile Neuronal Ceroid Lipofuscinosis (INCL)
$1,441,757Devin Thomas Wiley · Circumvent Pharmaceuticals, Inc. · R44 · FY2021 · NS
Genetic predictors of response to anti-TNF therapy in rheumatoid arthritis
$1,441,748Robert M Plenge · Brigham And Women'S Hospital · U01 · FY2011 · GM
Leukemia Signatures for Risk Classification & Targeting
$1,441,722Cheryl L Willman · University Of New Mexico · U01 · FY2009 · CA
Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias
$1,441,664Anumantha Gounder Kanthasamy · University Of Georgia · U01 · FY2025 · AG
Clinical Evaluation of an Innovative PSMA-targeted Radiotherapy, CTT1403, in Prostate Cancer
$1,441,580Beatrice Langton-Webster · Cancer Targeted Technology, Llc · R44 · FY2020 · CA
Optical Systems for In Vivo Molecular Imaging of Cancer
$1,441,255Rebecca Rae Richards-Kortum · Rice University · R01 · FY2008 · CA
KAPOSI'S SARCOMA: PATHOGENESIS AND NOVEL THERAPY
$1,440,823University Of Md Biotechnology Institute · P01 · FY2001 · CA